Table II.
Statistical analysis of gastric cancer clinical sample data from Oncomine database.
| Clinical data | Samples (n) | High expression of COUP-TFII (%) | Low expression of COUP-TFII (%) | χ2 | P-value |
|---|---|---|---|---|---|
| Total samples | 80 | 32 (40) | 48 (60) | 0.006 | |
| Age | 0.02 | >0.05 | |||
| >50 | 67 | 28 (41.8) | 39 (58.2) | ||
| <50 | 10 | 5 (50) | 5 (50) | ||
| Gender | 1.52 | >0.05 | |||
| Male | 52 | 25 (48) | 27 (52) | ||
| Female | 25 | 8 (32) | 17 (68) | ||
| Stage | 0.55 | >0.05 | |||
| 1–2 | 15 | 6 (40) | 9 (60) | ||
| 3–4 | 37 | 19 (51.4) | 18 (48.6) | ||
| Clinical stage | 22.4 | <0.01 | |||
| I–II | 11 | 3 (27.3) | 8 (72.7) | ||
| III–IV | 61 | 29 (47.5) | 32 (52.5) |
COUP-TFII, chicken ovalbumin upstream promoter transcription factor 2.